Gregory W Roloff

10PUBLICATIONS
55CO-AUTHORS
PhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|May 07, 2025
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand

|Mar 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.

Hannah Lust, Liora M Schultz, Soyang Kwon

Pageof 2

Frequent Collaborators

7 joint publications

Lori S Muffly

6 joint publications

Aaron C Logan

6 joint publications

Noelle V Frey

6 joint publications

Joshua Sasine